Shares of Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY – Get Free Report) gapped up before the market opened on Wednesday . The stock had previously closed at $9.5750, but opened at $10.20. Ambu A/S shares last traded at $10.20, with a volume of 597 shares traded.
Ambu A/S Stock Up 6.5%
The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.67 and a current ratio of 2.86. The firm’s 50 day moving average price is $10.43 and its two-hundred day moving average price is $12.29. The company has a market cap of $2.40 billion, a P/E ratio of 36.43 and a beta of 1.06.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last issued its earnings results on Wednesday, May 6th. The company reported $0.07 earnings per share (EPS) for the quarter. Ambu A/S had a net margin of 7.81% and a return on equity of 8.13%. The business had revenue of $246.39 million for the quarter.
Ambu A/S Company Profile
Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.
Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.
Read More
- Five stocks we like better than Ambu A/S
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
